Backgrounds/Aims: Stem cell therapies for liver disease are being studied by many researchers worldwide, but scientific evidence to demonstrate the endocrinologic effects of implanted cells is insufficient, and it is unknown whether implanted cells can function as liver cells. Achieving angiogenesis, arguably the most important characteristic of the liver, is known to be quite difficult, and no practical attempts have been made to achieve this outcome. We carried out this study to observe the possibility of angiogenesis of implanted bio-artificial liver using scaffolds. Methods: This study used adipose tissue-derived stem cells that were collected from adult patients with liver diseases with conditions similar to the liver parenchyma. Specifically, microfilaments were used to create an artificial membrane and maintain the structure of an artificial organ. After scratching the stomach surface of severe combined immunocompromised (SCID) mice (n=4), artificial scaffolds with adipose tissue-derived stem cells and type I collagen were implanted. Expression levels of angiogenesis markers including vascular endothelial growth factor (VEGF), CD34, and CD105 were immunohistochemically assessed after 30 days. Results: Grossly, the artificial scaffolds showed adhesion to the stomach and surrounding organs; however, there was no evidence of angiogenesis within the scaffolds; and VEGF, CD34, and CD105 expressions were not detected after 30 days. Conclusions: Although implantation of cells into artificial scaffolds did not facilitate angiogenesis, the artificial scaffolds made with type I collagen helped maintain implanted cells, and surrounding tissue reactions were rare. Our findings indicate that type I collagen artificial scaffolds can be considered as a possible implantable biomaterial. 
INTRODUCTION
There is an extreme worldwide lack of transplantable organs, and many patients are on waiting lists. According This demand and supply mismatch of organs is a persistent worldwide problem, [2] [3] [4] and although many studies have been carried out to identify viable alternatives to deceased donor organs, these projects remain in the early stages. 5 Part of this effort is a liver support system that is largely categorized into two systems. The first is an artificial liver support system that mainly focuses on detoxification also known as the Molecular Absorbent
Recirculating System (MARS TM ), and the second is a bio-artificial liver support system that detoxifies and has synthetic and regulatory functions. Unfortunately, these systems are extremely expensive, and problems with the membrane and biocompatibility make it unlikely that these solutions will be clinically viable. [6] [7] [8] Hepatocyte transplantation is another alternative. The donor's hepatocytes are integrated into the recipient's liver following their insertion into the portovenous system and subsequent translocation to the hepatic sinusoids. [9] [10] [11] This approach has been reported to be clinically effective in congenital metabolic diseases. For example, serum bilirubin levels are reportedly decreased by 25-50% after hepatocyte transplantation in patients with Crigler-Najjar syndrome. [12] [13] [14] [15] [16] However, the effect decreased with time, and patients eventually required whole liver transplantation due to hepatocyte graft failure after 4-48 months.
Regarding functional cell differentiation, there have been reports of endothelial cells producing dopamine, 17 pancreatic cells secreting insulin, 18 and cells functioning as hepatocytes. 19 In addition, cells differentiated from autologous cells that function as hepatocytes have been transplanted into human recipients, 20 but the lack of angiogenesis associated with these functional differentiated cells remains problematic.
Vasculogenesis and angiogenesis are unique processes.
The former is the formation of primary capillary blood vessels from mesodermal cells that first differentiate into angioblasts and then endothelial cells. 21 Angiogenesis involves the sprouting of new vessels from existing vessels. 21 This is a complex process that involves basement membrane degradation and proliferation, migration, and endothelial cell tube formation. Angiogenesis is critical for the development and wound healing of normal tissue, as well as ensuring adequate oxygen and nutrient supplies to transplanted tissues. 22 Angiogenesis is stimulated by hypoxia-inducible factors (HIFs) and the expression of many other signals including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and angiopoietin2 (Ang2). 23 VEGF is a signaling peptide that facilitates angiogenesis, 24 and immunohistochemical labeling of this protein has been used as a histological assessment tool. [25] [26] [27] It increases the permeability of endothelial cells and facilitates the creation of new vessels. 28 When overexpressed, it can facilitate the development of cancer, atherosclerosis, rheumatic arthritis, diabetic retinopathy, and so on. 29, 30 Other proteins such as CD31, CD34, CD105, and von is not precisely known, but it is used to identify gastrointestinal stromal tumors and solitary fibrous tumors. 33, 34 It is also used to assess the degree of angiogenesis. 27, [31] [32] [33] [34] [35] [36] [37] [38] [39] CD105 (endoglin) is a 180-kDa transmembrane glycoprotein, which is part of the transforming growth factor (TGF)- receptor complex. It controls angiogenesis by controlling cellular proliferation, differentiation, and migration. 40 Unlike the VEGF or CD34, CD105 is weakly expressed in normal tissue and blood vessels but is strongly expressed in tumors. [40] [41] [42] Immunohistochemical labeling for the proteins mentioned above is helpful for assessing the degree of angiogenesis in different model systems. 31, 35, [37] [38] [39] [43] [44] [45] In the present study, we collected adipose tissue-derived stem cells from adult patients with liver disease, placed them in artificial scaffolds, and implanted these scaffolds in severe combined immunocompromised (SCID) mice to determine whether they induced angiogenesis.
MATERIALS AND METHODS

Experimental model
We employed SCID mice as an experimental model to study angiogenesis in transplanted bio-artificial liver models ( Fig. 1) . Four scaffolds were transplanted considering possible errors and effectiveness. Adipose tissue-derived stem cells from human patients were implanted into the artificial scaffolds made of type I collagen, and the scaffolds were implanted into the stomach surface of SCID mice. Tissues attached to and near the scaffolds were analyzed 30 days after implantation, which is reportedly a sufficient period of time for adequate angiogenesis. 46, 47 The tissue was processed into frozen sections, and im- 
Tissue processing
The specimens including the artificial scaffolds were 
RESULTS
Gross findings
The gross findings in mice that were sacrificed and dissected 30 days after artificial scaffold implantation are shown in Fig. 3 . The artificial scaffolds were covered with the omentum and adhered to the fundus and pylorus suture areas, as well as to the surrounding organs.
H&E staining
We observed the H&E-stained artificial scaffolds under low magnification to assess their overall appearance. Fig.   4 shows collagen surrounding the scaffold that contained adipose tissue-derived stem cells. The collagen membrane was disrupted where the scaffold was sutured to fix it to the pylorus and fundus, and this membrane linked the artificial scaffold and the stomach.
We next observed the H&E-stained artificial scaffolds under high magnification to better assess its characteristics (Figs. 5, 6 ). The basement membrane surrounding the outer side of the artificial scaffold contained eosin-stained collagen without nuclei (Fig. 5) , and we also observed hematoxylin-stained adipose tissue-derived stem cells within the artificial scaffold (Fig. 6) .
Immunohistochemistry with VEGF, CD34, CD105 VEGF-labeled slides showed brown staining starting from the membrane of the artificial scaffold (Fig. 7A, B) , but there was no evidence of endothelial cells or vascular structure at ×200 magnification. Although collagen was stained brown by diaminobenzidine, the inside of the cells were not positive for VEGF (Fig. 7E, F) .
The inside and outside of the artificial membrane were assessed under high magnification to view cell shapes and differences in VEGF immunohistochemistry. Mouse omentum cells were observed outside the scaffold, and there was no positive staining for VEGF (Fig. 7E) . The inside of the artificial scaffold contained hematoxylin-stained adipose tissue-derived stem cells and diaminobenzidine-stained collagen but was negative for VEGF (Fig. 7F ).
CD34-labeled slides also showed progressive brown stain starting from the membrane of the artificial scaffold (Fig. 8A, B) , but again there was no sign of endothelial cells or vascular structures at ×200 magnification, and the inside of cells were negative for CD34 expression (Fig.   8D, E) . Both the inside and outside of the artificial scaffold were checked under high magnification in order to see the cell shape and difference in CD34 immunohistochemistry staining. Mouse omentum cells were observed outside the scaffold, and there was no positive staining for CD34 (Fig.   8E ). The inside of the artificial scaffold contained hematoxylin-stained adipose tissue-derived stem cells and diaminobenzidine-stained collagen but was negative for CD34 (Fig. 8F) .
The CD105 immunohistochemistry stained slide also showed progressive brown staining starting from the membrane of the artificial scaffold (Fig. 9A, B ). There were no endothelial cells or vascular structures at ×200 magnification, and the inside of the scaffold contained only stained collagen and was negative for CD105. Mouse omentum cells were observed outside the scaffold, and there was no positive staining for CD105 (Fig. 9E) . On the other hand, the inside of the artificial scaffold contained hematoxylin-stained adipose tissue-derived stem cells and diaminobenzidine-stained collagen but was negative for CD105 (Fig. 9F) . Microscopic observation failed to reveal any endothelial cells or vascular structures within the artificial scaffolds. Although diaminobenzidine-stained brown collagen was visible inside the scaffolds, the three angiogenesis markers were not expressed.
DISCUSSION
In the past 20 years, most tissue engineering projects have employed thin structures such as skin or vesical arteries. [48] [49] [50] Manufacturing thick tissues such as muscle, liver, and kidney on scaffolds was not considered possible due to insufficient diffusion of oxygen and nutrients. 51 To overcome this problem, the pig liver experimental model was developed by removing most of the cells and only leaving the vessels with mechanical perfusion. Still, microfilaments and microtubules were damaged in the process. 52 In the present study, we designed an experimental model under the assumption that vessels from the omentum will grow into the artificial scaffolds implanted onto the vessel-rich mouse stomach. In general, active liver regeneration occurs for 7 days after liver resection in mice, and most show regeneration within a month. 53 Previous studies reported that 30 days is a sufficient period of time for angiogenesis to occur. Therefore, we carried performed immunohistochemical labeling 1 month after artificial scaffold implantation. We expected to observe angiogenesis in the artificial scaffolds, but light microscopy of H&E-stained and antibody-labeled sections failed to reveal any evidence of angiogenesis.
There were diaminobenzidine-stained brown regions indicating that there could be transport of materials involved in angiogenesis from outside the artificial scaffold to inside. Specifically, the suture sites where the artificial scaffolds were fixed onto the mice appeared to contain connecting tracts. However, if there was angiogenesis from outside the artificial scaffolds, there would be evidence of endothelial cells or tubular structures inside the scaffolds, and these changes were not observed. In addition, only collagen was stained by diaminobenzidine; there was no evidence of angiogenesis marker expression.
There are several possible reasons why we were unable to find evidences of angiogenesis markers. First, previous studies used 12 weeks old C57bl/6 male mice, whereas we used SCID mice to prevent a reaction to the implanted adipose-derived stem cells. While our animal model choice might have helped maintain the adipose-derived stem cells I collagen into mice. 46 
